Stocks · News reference
OMRON (OTC:OMRNY) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.26 by 30.77 percent. This is a 41.67 percent increase over earnings of $0.24 per share from the same
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
OMRON (OTC:OMRNY) raises FY2026 GAAP EPS guidance from $0.89 to $1.29 vs $1.22 analyst estimate. Raises FY2026 sales outlook from $5.228 billion to $5.522 billion
Read original at benzingaThe global muscle stimulator market is valued at $812.01 million in 2025 and is projected to reach $1,156.54 million by 2035, growing at a CAGR of 3.6%. Growth is driven by increasing adoption of neuromuscular electrical stimulation devices for pain management, rehabilitation, and sports medicine. TENS technology dominates with 67.4% market share, while portable devices account for 46.88% of the market. North America leads with 41.9% revenue share, while Asia Pacific registers the fastest growth.
Read original at globenewswire-inc